Pacira Pharmaceuticals, Inc. Contracts & Agreements

Amendment No. 2 to Employment Agreement, dated June 30, 2015, between the Registrant and Lauren Riker (Filed With SEC on November 6, 2024)

Amendment No. 3 to Employment Agreement, dated August 16, 2024, between the Registrant and Lauren Riker (Filed With SEC on November 6, 2024)

Non-Healthcare Professional Consulting Agreement, effective October 1, 2024, between the Registrant and Charles. A. Reinhart, III (Filed With SEC on November 6, 2024)

Amended and Restated 2014 Inducement Plan (Filed With SEC on November 6, 2024)

Form of Nonstatutory Stock Option Agreement under the Amended and Restated 2014 Inducement Plan (Filed With SEC on November 6, 2024)

Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2014 Inducement Plan (Filed With SEC on November 6, 2024)

Amendment No. 1 to Executive Employment Agreement, dated as of (Filed With SEC on November 6, 2024)

Amendment No. 1 to Executive Employment, dated as of (Filed With SEC on November 6, 2024)

Amendment No. 3 to Employment Agreement, dated as of (Filed With SEC on November 6, 2024)

Amended and Restated Executive Employment Agreement, dated as of November 4, 2024, by and between Pacira Pharmaceuticals, Inc. and Lauren Riker (Filed With SEC on November 6, 2024)

Fifth Amendment to Consulting Agreement, dated June 12, 2024, between the Registrant and Gary Pace (Filed With SEC on July 30, 2024)

Indenture, dated as of May 14, 2024, by and between the Company and Computershare Trust Company, National Association (Filed With SEC on May 14, 2024)

Form of Capped Call Transaction Confirmation (Filed With SEC on May 14, 2024)

First Amendment, dated as of May 8, 2024, to Credit Agreement, dated as of March 31, 2023, by and among Pacira BioSciences, Inc., the lenders from time to time party thereto and... (Filed With SEC on May 8, 2024)

Specimen Certificate Evidencing Shares of Common Stock (Filed With SEC on February 29, 2024)

Form of Restricted Stock Unit Award Agreement (Employees) under the Amended and Restated 2011 Stock Incentive Plan for grants made prior to February 1, 2022 (Filed With SEC on February 29, 2024)

Form of Restricted Stock Unit Award Agreement (Non-Employee Directors) under the Amended and Restated 2011 Stock Incentive Plan for grants made prior to February 1, 2022 (Filed With SEC on February 29, 2024)

Form of Nonstatutory Stock Option Agreement under the Amended and Restated 2014 Inducement Plan (Filed With SEC on February 29, 2024)

Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2014 Inducement Plan (Filed With SEC on February 29, 2024)

Form of Indemnification Agreement between the Registrant and its directors and officers (Filed With SEC on February 29, 2024)

Commercial Outsourcing Services Agreement entered into as of February 26, 2024 by the Registrant and Integrated Commercialization Solutions, Inc (Filed With SEC on February 29, 2024)

First Amendment to Manufacturing and Supply Agreement dated May 8, 2019, between Flexion Therapeutics, Inc. and Patheon UK Limited (Filed With SEC on February 29, 2024)

Second Amendment to Manufacturing and Supply Agreement dated June 17, 2019, between Flexion Therapeutics, Inc. and Patheon UK Limited (Filed With SEC on February 29, 2024)

Third Amendment to Manufacturing and Supply Agreement dated December 1, 2023, by and between the Registrant and Patheon UK Limited (Filed With SEC on February 29, 2024)

Executive Employment Agreement, dated December 20, 2023, by and between Pacira Pharmaceuticals, Inc. and Frank Lee (Filed With SEC on December 21, 2023)

Pacira BioSciences, Inc. Amended and Restated 2014 Inducement Plan (Filed With SEC on December 21, 2023)

Transition and Retirement Agreement, dated September 20, 2023, between Pacira BioSciences, Inc. and David Stack (Filed With SEC on September 26, 2023)

Side Letter dated June 5, 2023, to the Manufacturing and Supply Agreement by and between the Registrant and Patheon UK Limited (Filed With SEC on August 2, 2023)

Executive Employment Agreement, dated June 17, 2019, between the Registrant and Daryl Gaugler (Filed With SEC on May 3, 2023)

Executive Employment Agreement, dated December 6, 2016, between the Registrant and Anthony Molloy (Filed With SEC on May 3, 2023)

Amendment No. 1 to Pacira BioSciences, Inc. Deferred Compensation Plan (Filed With SEC on February 28, 2023)

Amended and Restated 2014 Employee Stock Purchase Plan (Filed With SEC on June 10, 2022)

Executive Employment Agreement, dated May 4, 2020, between the Registrant and Jonathan Slonin (Filed With SEC on May 4, 2022)

Indenture (including form of 3.375% Convertible Senior Notes due 2024), dated as of May 2, 2017, by and between Flexion Therapeutics, Inc. and Wells Fargo Bank, National... (Filed With SEC on February 28, 2022)

First Supplemental Indenture, dated as of November 19, 2021, by and between Flexion Therapeutics, Inc. and Wells Fargo Bank, National Association, as trustee (Filed With SEC on February 28, 2022)

Form of Nonstatutory Stock Option Agreement (Employees) under the Amended and Restated 2011 Stock Incentive Plan for grants made on or after February 1, 2022 (Filed With SEC on February 28, 2022)

Form of Nonstatutory Stock Option Agreement (Non-Employee Directors) under the Amended and Restated 2011 Stock Incentive Plan for grants made on or after February 1, 2022 (Filed With SEC on February 28, 2022)

Manufacturing and Supply Agreement dated July 31, 2015, between Flexion Therapeutics, Inc. and Patheon UK Limited, as amended to date (Filed With SEC on February 28, 2022)

Technical Transfer and Service Agreement dated July 31, 2015, between Flexion Therapeutics, Inc. and Patheon UK Limited, as amended to date (Filed With SEC on February 28, 2022)

Side Letter to the Manufacturing and Supply Agreement between Flexion Therapeutics, Inc. and Patheon UK Limited, dated as of April 8, 2020 (Filed With SEC on February 28, 2022)

Contingent Value Right Agreement, dated as of November 19, 2021, by and between Pacira BioSciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 19, 2021)

Agreement and Plan of Merger, dated as of October 11, 2021, by and among Flexion Therapeutics, Inc., Pacira BioSciences, Inc. and Oyster Acquisition Company Inc (Filed With SEC on October 12, 2021)

Form of Tender and Support Agreement, dated as of October 11, 2021 (Filed With SEC on October 12, 2021)

Amended and Restated 2011 Stock Incentive Plan (Filed With SEC on June 11, 2021)

Executive Employment Agreement, dated June 1, 2020, between the Registrant and Donald Manning (Filed With SEC on May 4, 2021)

Pacira BioSciences, Inc. Long-Term Incentive Plan (Filed With SEC on December 7, 2020)

Indenture, dated as of July 10, 2020, by and between the Company and Wells Fargo Bank, National Association (Filed With SEC on July 10, 2020)

Pacira BioSciences, Inc. Deferred Compensation Plan (Filed With SEC on June 11, 2020)

Executive Employment Agreement, dated June 19, 2019, between the Registrant and Max Reinhardt (Filed With SEC on May 7, 2020)

Executive Employment Agreement, dated April 24, 2017, between the Registrant and Roy Winston (Filed With SEC on May 7, 2020)

Fourth through Eleventh Amendments to Commercial Outsourcing Services Agreement, between the Registrant and Integrated Commercialization Solutions, Inc (Filed With SEC on May 7, 2020)

Description of Securities (Filed With SEC on February 21, 2020)

Amended and Restated 2011 Stock Incentive Plan (Filed With SEC on August 8, 2019)

Amended and Restated 2011 Stock Incentive Plan (Filed With SEC on June 7, 2019)

Specimen Certificate Evidencing Shares of Common Stock (Filed With SEC on May 2, 2019)

Executive Employment Agreement, dated May 29, 2017, between the Registrant and Dennis McLoughlin (Filed With SEC on May 2, 2019)

Agreement and Plan of Merger, dated March 4, 2019, by and among Pacira Pharmaceuticals, Inc., PS Merger, Inc., MyoScience, Inc., and Fortis Advisors LLC, a Delaware limited... (Filed With SEC on March 5, 2019)

Second Amendment to Co-Promotion Agreement, dated December 21, 2018, between the Registrant and DePuy Synthes Sales, Inc (Filed With SEC on February 28, 2019)

Executive Employment Agreement, dated March 13, 2013, between the Registrant and Richard Scranton, M.D (Filed With SEC on August 2, 2018)

Amendment No. 1 to Executive Employment Agreement, dated June 30, 2015, between the Registrant and Richard Scranton, M.D (Filed With SEC on August 2, 2018)

First Amendment to Co-Promotion Agreement, dated April 19, 2018, between the Registrant and DePuy Synthes Sales, Inc (Filed With SEC on May 3, 2018)

Fourth Amendment, dated December 28, 2017, to the Industrial Real Estate Lease, dated December 8, 1994, between the Registrant and LASDK Limited Partnership (Filed With SEC on February 28, 2018)

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on May 4, 2017)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 4, 2017)

PACIRA PHARMACEUTICALS, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of March 13, 2017 2.375% Convertible Senior Notes due 2022 (Filed With SEC on March 13, 2017)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2016)

PACIRA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN (As approved by stockholders on June 14, 2016) (Filed With SEC on June 17, 2016)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 2, 2016)

FOURTH AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on February 25, 2016)

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on July 30, 2015)

AMENDMENT NO. 2 TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 30, 2015)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on July 30, 2015)

PACIRA PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD NOTICE AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN (Filed With SEC on July 30, 2015)

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on April 30, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on April 30, 2015)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on April 30, 2015)

AMENDMENT #4 TO SERVICES AGREEMENT (Filed With SEC on April 30, 2015)

AMENDMENT #5 TO SERVICES AGREEMENT (Filed With SEC on April 30, 2015)

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on October 30, 2014)

STRATEGIC CO-PRODUCTION AGREEMENT (Filed With SEC on July 31, 2014)

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on July 31, 2014)

PACIRA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN (As approved by stockholders on June 3, 2014) (Filed With SEC on June 4, 2014)

PACIRA PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN SECTION 1. PURPOSE (Filed With SEC on June 4, 2014)

PACIRA PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under Amended and Restated 2011 Stock Incentive Plan (Filed With SEC on June 4, 2014)

PACIRA PHARMACEUTICALS, INC. 2014 INDUCEMENT PLAN (Filed With SEC on May 1, 2014)

1,600,000 Shares Pacira Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 9, 2014)

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on February 25, 2014)

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on October 31, 2013)

AMENDMENT #3 TO SERVICES AGREEMENT (Filed With SEC on October 31, 2013)

THIRD AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on October 31, 2013)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. EXCLUSIVE LICENSE, DEVELOPMENT AND... (Filed With SEC on March 7, 2013)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. PACIRA PHARMACEUTICALS, INC. and ARATANA... (Filed With SEC on March 7, 2013)

PACIRA PHARMACEUTICALS, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of January 23, 2013 3.25% Convertible Senior Notes due 2019 (Filed With SEC on January 23, 2013)

SECOND AMENDED AND RESTATED CONSULTING AGREEMENT (Filed With SEC on November 1, 2012)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AIADocument A102TM 2007 (Filed With SEC on August 9, 2012)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. LOAN AND SECURITY AGREEMENT (Filed With SEC on August 9, 2012)

WARRANT TO PURCHASE STOCK No. 1 (Filed With SEC on August 9, 2012)

WARRANT TO PURCHASE STOCK No. 2 (Filed With SEC on August 9, 2012)

WARRANT TO PURCHASE STOCK No. 3 (Filed With SEC on August 9, 2012)

WARRANT TO PURCHASE STOCK No. 4 (Filed With SEC on August 9, 2012)

AMENDED AND RESTATED CONSULTING AGREEMENT (Filed With SEC on May 9, 2012)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2012)

6,000,000 Shares Pacira Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 12, 2012)

AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on December 9, 2011)

6,000,000 Shares Pacira Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 10, 2011)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COMMERCIAL OUTSOURCING SERVICES AGREEMENT (Filed With SEC on October 31, 2011)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. MASTER SERVICES AGREEMENT (Filed With SEC on October 31, 2011)

Confidential Materials omitted and filed separately with the Securities andExchange Commission. Asterisks denote omissions. (Filed With SEC on January 20, 2011)

[] Shares Pacira Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 13, 2011)

DATED 30th JUNE 2003 SKYEPHARMA INC and MUNDIPHARMA MEDICAL COMPANY SUPPLYAGREEMENT (Filed With SEC on January 13, 2011)

DATED 30th JUNE 2003 SKYEPHARMA INC and MUNDIPHARMA INTERNATIONAL HOLDINGS LIMITED DISTRIBUTION AGREEMENT 1 (Filed With SEC on January 13, 2011)

DATED July 27, 2005 SKYEPHARMA INC and MUNDIPHARMA INTERNATIONAL HOLDINGS LIMITED DISTRIBUTION AGREEMENT (Depocyte - Additional Territories) 1 (Filed With SEC on January 13, 2011)

DATED: OCTOBER 15, 2009 PACIRA PHARMACEUTICALS, INC. and EKR THERAPEUTICS, INC. AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (Filed With SEC on January 13, 2011)

AMENDED AND RESTATED SUPPLY AGREEMENT (Filed With SEC on January 13, 2011)

DATED SEPTEMBER 25, 2007 PACIRA PHARMACEUTICALS, INC. and FLYNN PHARMA LIMITED STRATEGIC MARKETING AGREEMENT (Filed With SEC on January 13, 2011)

PACIRA PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on January 13, 2011)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 3, 2011)

PACIRA PHARMACEUTICALS, INC. 2011 STOCK INCENTIVE PLAN (Filed With SEC on January 3, 2011)

ASSIGNMENT AGREEMENT (Filed With SEC on December 3, 2010)

STOCK PURCHASE AGREEMENT by and among Blue Acquisition Corp. (Buyer), SkyePharma Holding, Inc. (Seller), and SkyePharma, Inc. (the Company) dated as of January 8, 2007 (Filed With SEC on December 3, 2010)

AMENDED AND RESTATED ROYALTY INTERESTS ASSIGNMENT AGREEMENT Dated as of March 23, 2007 between SKYEPHARMA INC., as Seller, and ROYALTY SECURITIZATION TRUST I as Purchaser TABLE OF... (Filed With SEC on December 3, 2010)

AMENDED AND RESTATED SECURITY AGREEMENT (SKPI) Dated as of March 23, 2007 between SKYEPHARMA INC., as Grantor, and ROYALTY SECURITIZATION TRUST I, as Purchaser TABLE OF CONTENTS (Filed With SEC on December 3, 2010)

DATED 30th JUNE 2003 SKYEPHARMA INC and MUNDIPHARMA MEDICAL COMPANY SUPPLYAGREEMENT (Filed With SEC on December 3, 2010)

DATED 30th JUNE 2003 SKYEPHARMA INC and MUNDIPHARMA INTERNATIONAL HOLDINGS LIMITED DISTRIBUTION AGREEMENT 1 (Filed With SEC on December 3, 2010)

DATED July 27, 2005 SKYEPHARMA INC and MUNDIPHARMA INTERNATIONAL HOLDINGS LIMITED DISTRIBUTION AGREEMENT (Depocyte - Additional Territories) 1 (Filed With SEC on December 3, 2010)

CO-DEVELOPMENT, COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN ENZON PHARMACEUTICALS, INC. AND JAGOTEC, AG, SKYEPHARMA,INC., AND SKYEPHARMA PLC DATEDAS OF JANUARY 2, 2003... (Filed With SEC on December 3, 2010)

DEPOCYT® SUPPLY AND DISTRIBUTION AGREEMENT BY AND BETWEEN SKYEPHARMA, INC. AND ENZON PHARMACEUTICALS, INC. DATED AS OF DECEMBER 31, 2002 TABLE OF CONTENTS (Filed With SEC on December 3, 2010)

DATED: OCTOBER 15, 2009 PACIRA PHARMACEUTICALS, INC. and EKR THERAPEUTICS, INC. AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (Filed With SEC on December 3, 2010)

AMENDED AND RESTATED SUPPLY AGREEMENT (Filed With SEC on December 3, 2010)

DATED SEPTEMBER 25, 2007 PACIRA PHARMACEUTICALS, INC. and FLYNN PHARMA LIMITED STRATEGIC MARKETING AGREEMENT (Filed With SEC on December 3, 2010)

SUPPLY AGREEMENT (Filed With SEC on December 3, 2010)

SERVICES AGREEMENT (Filed With SEC on December 3, 2010)

PACIRA PHARMACEUTICALS, INC. Stack Pharmaceuticals, Inc. Services Agreement (Filed With SEC on December 3, 2010)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on December 3, 2010)

LOAN AND SECURITY AGREEMENT (Filed With SEC on December 3, 2010)

GUARANTY (Filed With SEC on December 3, 2010)

WARRANT AGREEMENT To Purchase Shares of Preferred Stock of Pacira Pharmaceuticals, Inc. Dated as of November 24, 2010 (the Effective Date) (Filed With SEC on December 3, 2010)

PACIRA, INC. SECOND AMENDED AND RESTATED 2007 STOCKOPTION/STOCK ISSUANCE PLAN1 ARTICLE ONE GENERAL PROVISIONS (Filed With SEC on November 1, 2010)

PACIRA, INC. STOCK OPTION AGREEMENT1 RECITALS (Filed With SEC on November 1, 2010)

BLUE ACQUISITION CORP. INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on November 1, 2010)

TORREY PINES SCIENCE PARK Industrial Real Estate Triple Net Lease BETWEEN EQUITABLE LIFE ASSURANCE SOCIETY OF THE UNITED STATES, A New York corporation, AS LANDLORD AND DEPOTECH... (Filed With SEC on November 1, 2010)

TORREY PINES SCIENCE CENTER Industrial Real Estate Lease BETWEEN LANKFORD & ASSOCIATES, INC., A COLORADO CORPORATION as LANDLORD and DEPOTECHCORPORATION, A CALIFORNIA CORPORATION... (Filed With SEC on November 1, 2010)

LOAN AND SECURITY AGREEMENT (Filed With SEC on November 1, 2010)

PROMISSORY NOTE (Filed With SEC on November 1, 2010)

PLEDGE AGREEMENT (Filed With SEC on November 1, 2010)

GUARANTY (Filed With SEC on November 1, 2010)

INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on November 1, 2010)

FORM OF WARRANT (Filed With SEC on November 1, 2010)

Category

Industry

Companies

Contracts

Pacira Pharmaceuticals, Inc. Contracts & Agreements